The Role of Technology in Vaccine Pharmacovigilance

Apr 4, 2018

There are several factors that increase the complexity of vaccine safety monitoring and pose challenges unique to vaccines as compared to drugs. For instance, prophylactic vaccines are required to have a higher level of safety than therapeutic medicinal products as they are given to healthy population. Download this white paper to learn about:
  • The Vaccine Pharmacovigilance Paradigm
  • Software Solutions for Vaccine Safety Management
  • Automation Technologies for Efficient Vaccine Safety Vigilance
  • ArisGlobal LifeSphere® Safety Platform
LATEST NEWS

About ArisGlobal

ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary Nava® cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® is a unified platform that boosts efficiency, ensures compliance, delivers actionable insights, and lowers total cost of ownership through multi-tenant SaaS architecture.

Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China. For more updates, follow ArisGlobal on LinkedIn and Twitter.

Additional Information

Connect with ArisGlobal on LinkedIn: linkedin.com/company/aris-global
Follow @Aris_Global on Twitter: twitter.com/aris_global

Contact

Alberto Cantor
ArisGlobal
+1 609-360-4042 | acantor@arisglobal.com